Evidence map›Paper›PMID 41892729›Full record

ArticleJournal of cardiovascular development and disease2026

First Reported Use of the AMDS Hybrid Prosthesis for Secondary Type A Aortic Dissection After Prior TEVAR.

Gjoko Boshkoski, Dorgam Natour, Atanas Jankulovski, Thomas Felderhoff, Aron F Popov

Abstract readCase Reports
In one paragraph

Article in Journal of cardiovascular development and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gjoko BoshkoskiDepartment of Cardiovascular Surgery, Asklepios Clinic Harburg, 21075 Hamburg, Germany.
Dorgam NatourDepartment of Cardiovascular Surgery, Asklepios Clinic Harburg, 21075 Hamburg, Germany.
Atanas JankulovskiDepartment of Cardiovascular Surgery, Asklepios Clinic Harburg, 21075 Hamburg, Germany.
Thomas FelderhoffDepartment of Cardiovascular Surgery, Asklepios Clinic Harburg, 21075 Hamburg, Germany.
Aron F PopovDepartment of Cardiovascular Surgery, Asklepios Clinic Harburg, 21075 Hamburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type A aortic dissection represents one of the most life-threatening cardiovascular emergencies, with management strategies evolving toward hybrid and endovascular approaches, particularly in high-risk patients. The Ascyrus Medical Dissection Stent (AMDS) is an emerging adjunctive technology designed to promote true lumen expansion and facilitate favorable aortic remodeling during open repair of acute Type A dissection. We present the first reported case of AMDS deployment in secondary Type A dissection following prior thoracic endovascular aortic repair (TEVAR). An 83-year-old female with extensive aortic history-including TEVAR in 2012 for intramural hematoma with chimney stenting to the left subclavian artery and carotid-subclavian bypass in 2013-developed acute Type A dissection extending into the existing stent graft in 2024. Emergency surgical intervention included ascending aortic replacement, aortic arch repair with AMDS implantation, aortic valve resuspension, and left atrial appendage resection under cardiopulmonary bypass and hypothermic circulatory arrest. Postoperative imaging confirmed appropriate AMDS positioning, false lumen exclusion, and preservation of prior endograft integrity. The patient tolerated the procedure well and was discharged in stable condition with favorable early follow-up outcomes. This case demonstrates the potential role of hybrid surgical strategies and adjunctive endovascular devices in managing complex, multi-stage aortic disease.

Indexed as

AMDS stentaorta diseasesaortic arch repairascending aorta replacementhybrid aortic surgeryTEVARtype A aortic dissectiontype B aortic dissection

Identifiers

PMID41892729
PMCPMC13027261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.